Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 3;7(2):rkad037.
doi: 10.1093/rap/rkad037. eCollection 2023.

Nintedanib for progressive fibrosing interstitial lung disease: how many meet criteria in a UK district general hospital systemic sclerosis cohort?

Gen Nen Ho  1 , Karen May Jane Douglas  1
Affiliations

Nintedanib for progressive fibrosing interstitial lung disease: how many meet criteria in a UK district general hospital systemic sclerosis cohort?

Gen Nen Ho et al. Rheumatol Adv Pract. .
No abstract available

PubMed Disclaimer

References

    1. National Institute for Health and Care Excellence (NICE) committee. Overview | Nintedanib for treating progressive fibrosing interstitial lung diseases | Guidance | NICE. NICE. https://www.nice.org.uk/guidance/ta747 (29 November 2022, date last accessed).
    1. Olson A, Hartmann N, Patnaik P. et al. Estimation of the prevalence of progressive fibrosing interstitial lung diseases: systematic literature review and data from a physician survey. Adv Ther 2021;38:854–67. - PMC - PubMed
    1. Flaherty KR, Wells AU, Cottin V. et al.; INBUILD Trial Investigators. Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 2019;381:1718–27. - PubMed
    1. National Institute for Health and Care Excellence (NICE) committee. TA747 Resource Impact Report. https://www.nice.org.uk/guidance/ta747/resources/resource-impact-report-... (5 June 2022, date last accessed).
    1. Torrisi SE, Kahn N, Wälscher J. et al. Outcomes and incidence of PF-ILD according to different definitions in a real-world setting. Front Pharmacol 2021;12:790204. - PMC - PubMed

LinkOut - more resources